PFE -
Pfizer Inc.
25.18
+0.28 (+1.12%)
As of January 2, 2026 4:01 pm EST
Quote Detail
| Last | 25.18 |
|---|---|
| Change | 0.28 |
| Change % | 1.12 |
| Bid | 25.18 X 100 |
| Ask | 25.2 X 100 |
| Volume | 35.98 M |
| Shares | 5.69 B |
| Market Cap | 141.57 B |
| Open | 24.98 |
|---|---|
| High | 25.30 |
| Low | 24.83 |
| Prev Close | 24.90 |
| 52 Wk High | 27.69 |
| 52 Wk Low | 20.92 |
| EPS | 1.7243 |
| P/E | 14.51 |
| Div Yield | 6.83 |
Market Headlines
PADCEV" Plus Keytruda® Significantly Improves Survival for Patients with Muscle-Invasive Bladder Cancer Regardless of Cisplatin Eligibility
TOKYO and NEW YORK, Dec. 17, 2025 /PRNewswire via COMTEX News Network/ -- -- PADCEV plus Keytruda is the first and only regimen without platinum-based chemotherapy to improve event-free and overall...
Fosun Pharma's Subsidiary Yao Pharma and Pfizer Enter into Exclusive Collaboration and License Agreement
SHANGHAI, Dec. 9, 2025 /PRNewswire via COMTEX News Network/ -- Fosun Pharma (SSE: 600196; HKEX: 02196) today announced that its subsidiaries, Chongqing Yao Pharmaceutical Company, Limited. ("Yao...
Chronic Rare Diseases in an Aging America: Why HyBryte and Federal Policy Matter Now
Dec 02, 2025 (Investor Brand Network via COMTEX News Network) -- BioMedWire Editorial Coverage: Chronic conditions and rare diseases in the aging population present an urgent and expanding...
